Nanomaterials used in cancer treatment based on drug delivery system

Yi Xu

doi:10.1117/12.3013205

8 January 2024 Nanomaterials used in cancer treatment based on drug delivery system

Yi Xu

Proceedings Volume 12924, Third International Conference on Biological Engineering and Medical Science (ICBioMed2023); 1292420 (2024) https://doi.org/10.1117/12.3013205
Event: 3rd International Conference on Biological Engineering and Medical Science (ICBioMed2023), 2023, ONLINE, United Kingdom

Abstract

Cancer is produced by the malignant proliferation of normal cells. Nano drug delivery system (DDS) refers to a medical method that utilizes nanomaterials or nanotechnology to accurately deliver anticancer drugs to cancer cells. Nano DDS has high specificity and can avoid affecting normal cells, achieving the goal of killing cancer cells. This review summarizes the working principles, classifications, and designs of nanocarriers. It also analyzes the difficulties that need to be overcome in converting nanomaterials into clinical applications and also discusses the areas where future nanomaterials still need improvement. Although nanomaterials have been widely used in cancer treatment to enhance specificity and reduce toxicity, side effects cannot be ignored. For example, the toxicity of nanomaterials themselves is still unknown, and whether nanomaterials will react with drugs to cause harm to the human body. Further study is required on the targeted medication delivery of nanomaterials to optimize the avoidance of pharmaceuticals being filtered by the human body's own barrier during the delivery process, minimizing toxicity and improving specificity, in order to enhance clinical treatment effectiveness.

(2024) Published by SPIE. Downloading of the abstract is permitted for personal use only.

Citation Download Citation

Yi Xu "Nanomaterials used in cancer treatment based on drug delivery system", Proc. SPIE 12924, Third International Conference on Biological Engineering and Medical Science (ICBioMed2023), 1292420 (8 January 2024); https://doi.org/10.1117/12.3013205

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available